BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 31058420)

  • 1. Stabilizing Antibody Cocktails for Mass Cytometry.
    Schulz AR; Baumgart S; Schulze J; Urbicht M; Grützkau A; Mei HE
    Cytometry A; 2019 Aug; 95(8):910-916. PubMed ID: 31058420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface Barcoding of Live PBMC for Multiplexed Mass Cytometry.
    Schulz AR; Mei HE
    Methods Mol Biol; 2019; 1989():93-108. PubMed ID: 31077101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platinum-conjugated antibodies for application in mass cytometry.
    Mei HE; Leipold MD; Maecker HT
    Cytometry A; 2016 Mar; 89(3):292-300. PubMed ID: 26355391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotyping of Human Peripheral Blood Mononuclear Cells by Mass Cytometry.
    Heck S; Bishop CJ; Ellis RJ
    Methods Mol Biol; 2019; 1979():285-303. PubMed ID: 31028645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic mass tag of bismuth-209 for increasing the immunoassay multiplexing capacity of mass cytometry.
    Han G; Chen SY; Gonzalez VD; Zunder ER; Fantl WJ; Nolan GP
    Cytometry A; 2017 Dec; 91(12):1150-1163. PubMed ID: 29205767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unlabeled Competitor Antibody to Reduce Nonlinear Signal Spillover in Mass Cytometry.
    Sekhri P; Kim MY; Behbehani GK
    Cytometry A; 2019 Aug; 95(8):898-909. PubMed ID: 31120628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CyTOF assays across sites: Results of a six-center pilot study.
    Leipold MD; Obermoser G; Fenwick C; Kleinstuber K; Rashidi N; McNevin JP; Nau AN; Wagar LE; Rozot V; Davis MM; DeRosa S; Pantaleo G; Scriba TJ; Walker BD; Olsen LR; Maecker HT
    J Immunol Methods; 2018 Feb; 453():37-43. PubMed ID: 29174717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-isotope-tagged monoclonal antibodies for high-dimensional mass cytometry.
    Han G; Spitzer MH; Bendall SC; Fantl WJ; Nolan GP
    Nat Protoc; 2018 Oct; 13(10):2121-2148. PubMed ID: 30258176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Titration of Mass Cytometry Reagents.
    van Vreden C; Niewold P; McGuire HM; Fazekas de St Groth B
    Methods Mol Biol; 2019; 1989():83-92. PubMed ID: 31077100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced multiplexing in mass cytometry using osmium and ruthenium tetroxide species.
    Catena R; Özcan A; Zivanovic N; Bodenmiller B
    Cytometry A; 2016 May; 89(5):491-7. PubMed ID: 27018769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Measurement of Cell-Nanoparticle Interactions Using Mass Cytometry.
    Mitchell AJ; Ivask A; Ju Y
    Methods Mol Biol; 2019; 1989():227-241. PubMed ID: 31077109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broad Immune Monitoring and Profiling of T Cell Subsets with Mass Cytometry.
    Brodie TM; Tosevski V
    Methods Mol Biol; 2018; 1745():67-82. PubMed ID: 29476463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scalable Conjugation and Characterization of Immunoglobulins with Stable Mass Isotope Reporters for Single-Cell Mass Cytometry Analysis.
    Hartmann FJ; Simonds EF; Vivanco N; Bruce T; Borges L; Nolan GP; Spitzer MH; Bendall SC
    Methods Mol Biol; 2019; 1989():55-81. PubMed ID: 31077099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of Mass Cytometry Signal Background to Enable Optimal Core Panel Customization and Signal Threshold Gating.
    Au-Yeung A; Takahashi C; Mathews WR; O'Gorman WE
    Methods Mol Biol; 2019; 1989():35-45. PubMed ID: 31077097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Throughput Mass Cytometry Staining for Immunophenotyping Clinical Samples.
    Thrash EM; Kleinsteuber K; Hathaway ES; Nazzaro M; Haas E; Hodi FS; Severgnini M
    STAR Protoc; 2020 Sep; 1(2):100055. PubMed ID: 33111099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Harmonized analysis of PBMC by mass cytometry.
    Schulz AR; Rademacher J; Bockhorn V; Mei HE
    Methods Cell Biol; 2024; 186():107-130. PubMed ID: 38705596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent Cell Barcoding for Immunophenotyping.
    Giudice V; Fantoni G; Biancotto A
    Methods Mol Biol; 2019; 2032():53-68. PubMed ID: 31522412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotyping of tumor infiltrating immune cells using mass-cytometry (CyTOF).
    Maby P; Corneau A; Galon J
    Methods Enzymol; 2020; 632():339-368. PubMed ID: 32000904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Dimensional Single-Cell Analysis with Mass Cytometry.
    Brodie TM; Tosevski V
    Curr Protoc Immunol; 2017 Aug; 118():5.11.1-5.11.25. PubMed ID: 28762483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardization and quality control for high-dimensional mass cytometry studies of human samples.
    Kleinsteuber K; Corleis B; Rashidi N; Nchinda N; Lisanti A; Cho JL; Medoff BD; Kwon D; Walker BD
    Cytometry A; 2016 Oct; 89(10):903-913. PubMed ID: 27575385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.